lovastatin and leptin
lovastatin has been researched along with leptin in 6 studies
Research
Studies (6)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Fuh, MM; Hung, YJ; Jeng, C; Kuo, SW; Pei, D; Wu, DA | 1 |
Chiariello, M; Cirillo, P; De Rosa, S; Di Palma, V; Pacileo, M; Paglia, A | 1 |
Jan, MS; Lee, CY; Lin, CC; Shih, HC; Wei, JC; Yu, MC | 1 |
Elfakhani, M; Hussein, D; Mills, N; Mo, H; Torabi, S; Verbeck, GF | 1 |
Argani, H; Azizi, T; Gholamin, S; Ghorbanihaghjo, A; Rashtchizadeh, N; Razavi, SM; Safa, J; Taghavi-Garmestani, SM; Vatankhah, AM | 1 |
Ahmadi, F; Mohebi-Nejad, A | 1 |
Trials
2 trial(s) available for lovastatin and leptin
Article | Year |
---|---|
Relationship between adiponectin and leptin, and blood lipids in hyperlipidemia patients treated with red yeast rice.
Topics: Adiponectin; Adult; Biological Products; Body Mass Index; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Dietary Supplements; Drug Combinations; Female; gamma-Aminobutyric Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertriglyceridemia; Intention to Treat Analysis; Leptin; Lipids; Lovastatin; Male; Medicine, Chinese Traditional; Middle Aged; Treatment Outcome | 2013 |
Lovastatin for reduction of leptin in nondialysis patients with type 2 diabetic nephropathy.
Topics: Adult; C-Reactive Protein; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Failure, Chronic; Leptin; Lovastatin; Male; Middle Aged | 2014 |
Other Studies
4 other study(ies) available for lovastatin and leptin
Article | Year |
---|---|
Effects of lovastatin and gemfibrozil in subjects with high ratios of total cholesterol to high-density lipoprotein cholesterol.
Topics: Adult; Aged; Anticholesteremic Agents; Blood Glucose; Cholesterol; Cholesterol, HDL; Female; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Insulin; Leptin; Lovastatin; Male; Middle Aged; Obesity; Proteins | 1999 |
Leptin stimulated C-reactive protein production by human coronary artery endothelial cells.
Topics: Butadienes; C-Reactive Protein; Carbazoles; Cells, Cultured; Coronary Vessels; Endothelial Cells; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Leptin; Lovastatin; Maleimides; Nitriles; Protein Kinase C; Protein Kinase C beta; Protein Kinase Inhibitors; rho-Associated Kinases; rhoA GTP-Binding Protein; RNA, Messenger; Signal Transduction; Transcription, Genetic; Up-Regulation | 2009 |
Mevalonate deprivation mediates the impact of lovastatin on the differentiation of murine 3T3-F442A preadipocytes.
Topics: 3T3 Cells; Adipocytes; Adipogenesis; Adiponectin; Animals; CCAAT-Enhancer-Binding Proteins; Cell Survival; Down-Regulation; Fatty Acid-Binding Proteins; Gene Expression; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin Resistance; Leptin; Lovastatin; Mevalonic Acid; Mice; PPAR gamma; Sterol Regulatory Element Binding Protein 1; Triglycerides | 2014 |
Re: Lovastatin for reduction of leptin in nondialysis patients with type 2 diabetic nephropathy.
Topics: Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Failure, Chronic; Leptin; Lovastatin; Male | 2014 |